Not recruiting
Rectal cancer
Not recruitingStudy on Chemotherapy and Pelvic Reirradiation for Patients with Recurrent Rectal Cancer Using Irinotecan, Levoleucovorin, Fluorouracil, Oxaliplatin, and Capecitabine
Registered drugNo placebo
Study on Chemotherapy and Pelvic Reirradiation for Patients with Recurrent Rectal Cancer Using Irinotecan, Levoleucovorin, Fluorouracil, Oxaliplatin, and Capecitabine
Registered drugNo placebo
- Disease:Rectal cancer
- Substances:CapecitabineFluorouracil+3
Countries:
France
France- Participants:18–64 years · 65+ years
- Substances:Capecitabine
